Document is current
Any future updates will be listed below
-
Authors
Lou, Song
DJiake Tihagam, Rachisan
Wasko, Urszula N.
Equbal, Zaffar https://orcid.org/0000-0001-7791-1804
Venkatesan, Sanjay
Braczyk, Klaudia
Przanowski, Piotr
Il Koo, Bon
Saltani, Ilyas
Singh, Arjun Tushir
Likhite, Shibi
Powers, Samantha
Souza, George M. P. R.
Maxwell, Robert A.
Yu, Jun
Zhu, Lihua J. https://orcid.org/0000-0001-7416-0590
Beenhakker, Mark
Abbott, Stephen B. G. https://orcid.org/0000-0003-1244-3637
Lu, Zhipeng
Green, Michael R. https://orcid.org/0000-0003-3017-3298
Meyer, Kathrin C.
Tushir-Singh, Jogender
Bhatnagar, Sanchita https://orcid.org/0000-0002-3588-7874
-
Funding
Funding for this research was provided by:
Hartwell Foundation
- License Information
-
More Information
Article History
Received: 11 March 2025
Accepted: 12 June 2025
First Online: 4 July 2025
Competing interests
: S.B., J.T.S., and K.M. are inventors on the patent application for X reactivation technology. S.B. is funded by a research grant from Alcyone Therapeutics Inc. K.M. serves as the Chief Scientific Officer at Alcyone Therapeutics Inc. S.B. and K.M. declare financial interests in Alcyone Therapeutics Inc. All other authors declare no competing interests.
